Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,330
-10 (-0.07%)
Last updated: Apr 17, 2025

Daewon Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
598,162526,952478,885354,176308,501
Upgrade
Other Revenue
-0-0-0-00
Upgrade
Revenue
598,162526,952478,885354,176308,501
Upgrade
Revenue Growth (YoY)
13.51%10.04%35.21%14.81%-2.93%
Upgrade
Cost of Revenue
312,188271,808243,038179,630144,354
Upgrade
Gross Profit
285,974255,144235,847174,546164,147
Upgrade
Selling, General & Admin
226,957198,507173,719144,585135,522
Upgrade
Research & Development
21,92618,20712,646--
Upgrade
Other Operating Expenses
3,2422,9512,3208,0092,080
Upgrade
Operating Expenses
259,297222,911192,943155,243140,168
Upgrade
Operating Income
26,67732,23342,90419,30323,979
Upgrade
Interest Expense
-9,306-4,614-3,683-2,078-1,182
Upgrade
Interest & Investment Income
1,6641,4161,259532.2281.72
Upgrade
Earnings From Equity Investments
996.46509.42860.08382.62517.27
Upgrade
Currency Exchange Gain (Loss)
156.06121.26219.8271.59-91.69
Upgrade
Other Non Operating Income (Expenses)
1,354672.8823.15906.98-1,139
Upgrade
EBT Excluding Unusual Items
21,54130,33841,58319,11922,365
Upgrade
Gain (Loss) on Sale of Investments
-1,149-61.5-752.76-870.391,990
Upgrade
Gain (Loss) on Sale of Assets
-312.09149.9545.71-0.862.34
Upgrade
Asset Writedown
-3,921-4,597-2,154-1,111-715.77
Upgrade
Pretax Income
16,15925,83038,72217,13623,642
Upgrade
Income Tax Expense
6,0552,3678,06510,5256,443
Upgrade
Earnings From Continuing Operations
10,10423,46330,6576,61117,198
Upgrade
Earnings From Discontinued Operations
-1,059----
Upgrade
Net Income to Company
9,04523,46330,6576,61117,198
Upgrade
Minority Interest in Earnings
5,165453.671,287378.15441.9
Upgrade
Net Income
14,21023,91731,9446,98917,640
Upgrade
Net Income to Common
14,21023,91731,9446,98917,640
Upgrade
Net Income Growth
-40.59%-25.13%357.08%-60.38%-35.36%
Upgrade
Shares Outstanding (Basic)
2121212121
Upgrade
Shares Outstanding (Diluted)
2222222121
Upgrade
Shares Change (YoY)
--0.98%3.09%-0.58%-1.06%
Upgrade
EPS (Basic)
667.431139.911509.75329.36826.54
Upgrade
EPS (Diluted)
656.021110.441478.37329.36826.54
Upgrade
EPS Growth
-40.92%-24.89%348.86%-60.15%-34.66%
Upgrade
Free Cash Flow
-4,82939,44618,40518,30913,605
Upgrade
Free Cash Flow Per Share
-222.961821.12841.34862.87637.47
Upgrade
Dividend Per Share
---194.175155.340
Upgrade
Dividend Growth
---25.00%-33.45%
Upgrade
Gross Margin
47.81%48.42%49.25%49.28%53.21%
Upgrade
Operating Margin
4.46%6.12%8.96%5.45%7.77%
Upgrade
Profit Margin
2.38%4.54%6.67%1.97%5.72%
Upgrade
Free Cash Flow Margin
-0.81%7.49%3.84%5.17%4.41%
Upgrade
EBITDA
46,77149,79462,27237,10939,652
Upgrade
EBITDA Margin
7.82%9.45%13.00%10.48%12.85%
Upgrade
D&A For EBITDA
20,09517,56119,36817,80515,674
Upgrade
EBIT
26,67732,23342,90419,30323,979
Upgrade
EBIT Margin
4.46%6.12%8.96%5.45%7.77%
Upgrade
Effective Tax Rate
37.47%9.16%20.83%61.42%27.25%
Upgrade
Advertising Expenses
33,92329,70127,19926,27223,013
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.